1. Home
  2. LTRN vs LGL Comparison

LTRN vs LGL Comparison

Compare LTRN & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • LGL
  • Stock Information
  • Founded
  • LTRN 2013
  • LGL 1917
  • Country
  • LTRN United States
  • LGL United States
  • Employees
  • LTRN N/A
  • LGL N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • LGL Industrial Machinery/Components
  • Sector
  • LTRN Health Care
  • LGL Technology
  • Exchange
  • LTRN Nasdaq
  • LGL Nasdaq
  • Market Cap
  • LTRN 36.0M
  • LGL 35.6M
  • IPO Year
  • LTRN 2020
  • LGL N/A
  • Fundamental
  • Price
  • LTRN $3.16
  • LGL $6.87
  • Analyst Decision
  • LTRN Strong Buy
  • LGL
  • Analyst Count
  • LTRN 1
  • LGL 0
  • Target Price
  • LTRN $25.00
  • LGL N/A
  • AVG Volume (30 Days)
  • LTRN 50.9K
  • LGL 38.9K
  • Earning Date
  • LTRN 08-07-2025
  • LGL 08-12-2025
  • Dividend Yield
  • LTRN N/A
  • LGL N/A
  • EPS Growth
  • LTRN N/A
  • LGL 204.51
  • EPS
  • LTRN N/A
  • LGL 0.08
  • Revenue
  • LTRN N/A
  • LGL $4,322,000.00
  • Revenue This Year
  • LTRN N/A
  • LGL N/A
  • Revenue Next Year
  • LTRN N/A
  • LGL N/A
  • P/E Ratio
  • LTRN N/A
  • LGL $95.56
  • Revenue Growth
  • LTRN N/A
  • LGL 20.66
  • 52 Week Low
  • LTRN $2.55
  • LGL $5.03
  • 52 Week High
  • LTRN $6.12
  • LGL $9.74
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 46.11
  • LGL 60.84
  • Support Level
  • LTRN $3.05
  • LGL $5.88
  • Resistance Level
  • LTRN $3.33
  • LGL $9.74
  • Average True Range (ATR)
  • LTRN 0.18
  • LGL 0.87
  • MACD
  • LTRN 0.01
  • LGL 0.05
  • Stochastic Oscillator
  • LTRN 26.19
  • LGL 34.97

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

Share on Social Networks: